Literature DB >> 12016247

Thrombolysis for acute ischemic stroke: still a treatment for the few by the few.

Joanna M Wardlaw1, Richard I Lindley, Steff Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016247      PMCID: PMC1071716          DOI: 10.1136/ewjm.176.3.198

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  3 in total

Review 1.  The high cost of not funding stroke research: a comparison with heart disease and cancer.

Authors:  P M Rothwell
Journal:  Lancet       Date:  2001-05-19       Impact factor: 79.321

2.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

3.  The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?

Authors:  C E Counsell; M J Clarke; J Slattery; P A Sandercock
Journal:  BMJ       Date:  1994 Dec 24-31
  3 in total
  4 in total

Review 1.  Thrombolysis in acute ischaemic stroke: a guide to patient selection.

Authors:  Richard I Lindley
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Rationale for a nanomedicine approach to thrombolytic therapy.

Authors:  Gregory M Lanza; Jon N Marsh; Grace Hu; Michael J Scott; Anne H Schmieder; Shelton D Caruthers; Dipanjan Pan; Samuel A Wickline
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

3.  A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke.

Authors:  Jon N Marsh; Grace Hu; Michael J Scott; Huiying Zhang; Matthew J Goette; Patrick J Gaffney; Shelton D Caruthers; Samuel A Wickline; Dana Abendschein; Gregory M Lanza
Journal:  Nanomedicine (Lond)       Date:  2011-04-20       Impact factor: 5.307

Review 4.  Thrombolysis for acute ischaemic stroke.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory J del Zoppo
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.